Related Experiment Video
Updated: Apr 20, 2026
Live-3D-Cell Immunocytochemistry Assays of Pediatric Diffuse Midline Glioma
Published on: November 11, 2021
[Pediatric Gliosarcoma: Case Report and Literature Review]
Insights
Brain gliosarcoma, a rare aggressive brain cancer, can affect young children. This case study details a successful treatment approach in a four-year-old, highlighting the importance of surgical resection for survival.
Area of Science:
- Neuro-oncology
- Pediatric oncology
- Cancer pathology
Background:
- Brain gliosarcoma is a rare, aggressive subtype of glioblastoma multiforme.
- Typically diagnosed in older adults (60-70 years old), pediatric cases are exceptionally rare.
- This highlights a knowledge gap in understanding pediatric gliosarcoma presentation and management.
Observation:
- A four-year-old male presented with clinical, imaging, and pathological findings consistent with brain gliosarcoma.
- The patient underwent surgical resection followed by adjuvant radiotherapy.
- Post-treatment follow-up showed no recurrence or neurological deficits.
Findings:
- The successful management of a pediatric brain gliosarcoma case.
- Demonstrates that aggressive treatment, including surgery and radiotherapy, can be effective in young patients.
- This contrasts with the generally poor prognosis associated with this tumor type.
Implications:
- This case suggests that pediatric brain gliosarcoma, while rare, is treatable.
- Aggressive surgical resection is crucial for improving patient outcomes and survival.
- Further research is needed to optimize treatment protocols for children diagnosed with gliosarcoma.
Abstract:
Brain gliosarcoma is a rare variant of glioblastoma multiforme that occurs primarily between the sixth and seventh decades of life. Few cases have been reported in patients younger than nineteen years. We report a four-year-old male with clinical, imaging and pathology compatible with brain gliosarcoma. Beside surgery he was managed with adjuvant radiotherapy and after follow-up is free of recurrence or neurologic deficit. Brain gliosarcoma is highly aggressive and the median survival is related to the extent of surgical resection.
